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Conversion of a T Cell Antagonist into an Agonist
by Repairing a Defect in the TCR/Peptide/MHC
Interface: Implications for TCR Signaling
This view is supported by the data of Lyons et al. (1996),
in which the binding of the mouse abTCR 2B4 to the
mouse class II MHC I-Ek complexed with six altered
peptides (one agonist, two weak agonists, and three
antagonists) was investigated. The conclusion was that
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the TCR recognized the agonist ligand with the strongest†Howard Hughes Medical Institute
affinity and slowest off rate (longest half-life), followed7 Divinity Avenue
by the weak agonists, which were recognized with inter-Cambridge, Massachusetts 02138
mediate affinities and off rates. The antagonist ligands‡Molecular Immunology Section
in turn were recognized with the weakest affinity and theNeuroimmunology Branch
fastest off rates, although it was necessary to measureNational Institute of Neurological Disorders
dissociation rates for the antagonists with an indirectand Stroke
method (van der Merwe et al., 1994). Kersh et al. (1998)National Institutes of Health
presented a stronger correlation between TCR activityBethesda, Maryland 20892
and dissociation rate, reporting kinetics and affinities
for the mouse abTCR 3.L2 binding to the class II MHC
I-Ek complexed with four altered peptides (a full agonist,Summary
a weak agonist, a weak agonist/antagonist, and an an-
tagonist). Although the ligands were reported to haveThe structure of the A6 abTCR/HTLV-1 Tax-peptide/
similar TCR affinities, there was more variability amongMHC I complex with proline 6 of Tax substituted with
the dissociation rates, with the antagonist ligand disso-alanine (P6A), an antagonist, is nearly identical to the
ciating the fastest and the agonist the slowest. As dis-structure with wild-type Tax agonist. Neither the pro-
cussed by the authors, however, only very small portionsline in the agonist nor the alanine in the antagonist is
of the kinetic data could be fit to determine rates. Also,contacted by the abTCR. Here, we demonstrate that
the Biacore data, as presented, were not corrected forantagonist activity of P6A is associated with low affin-
bulk refractive index changes, contributing to disagree-ity of the A6 abTCR for Tax-P6A/HLA-A2. We show
ment between affinities determined from kinetic andthat stepwise repair of a packing defect in the TCR/
equilibrium experiments (Myszka, 1999). A correlationMHC interface using N-alkylated amino acids results in
between TCR activity and dissociation rate was ques-stepwise increases in TCR affinity and activity. Kinetic
tioned by Alam et al. (1996), who characterized the bind-and thermodynamic measurements suggest that for
ing of the mouse abTCR 42.12 to the class I MHC H-2Kbsome ligands the range of T cell outcomes does not
complexed with four altered peptides (one agonist, onecorrelate with either their abTCR affinity or the half-
weak agonist, and two antagonists). As with the data oflife of the abTCR/peptide/MHC complex.
Lyons et al. (1996), a correlation was found between
activity and affinity, with the antagonist ligands havingIntroduction
the weakest TCR affinity, the weak agonist ligands inter-
mediate, and the agonist ligands the strongest. How-Binding of the TCR to class I or class II MHC molecules
ever, a poorer correlation was observed between activitycomplexed with peptide is necessary for T cell activation
and dissociation rate, as the TCR/peptide/MHC com-and initiation of a cell-mediated immune response. Sim-
plex with one of the antagonist peptides had a half-life
ple alterations to antigenic peptides can result in a range
almost twice as long as that observed with the weak
of effects from loss of TCR signaling to weak or partial
agonist. This prompted the authors to suggest that cor-
signaling or to the phenomenon of TCR antagonism relations observed between activity and dissociation
(Sloan-Lancaster and Allen, 1996). Antagonist peptides rate may be coincidental, reflecting an underlying corre-
do not normally produce any of the outcomes associ- lation with affinity.
ated with activation but result in an inhibition of the T X-ray crystallographic structures of abTCR/peptide/
cell response when the cell is subsequently challenged MHC complexes suggest that the entire range of TCR-
with an activating agonist peptide. initiated signals, including antagonism, weak agonism,
Binding measurements for a variety of abTCR/pep- and full agonism, can be generated with only minor dif-
tide/MHC interactions suggest that the range of T cell ferences in either the conformation of the bound TCR
responses results from differences in either TCR affinity or its diagonal binding mode to peptide/MHC. Three
or dissociation rate (e.g., Matsui et al., 1994; Alam et al., crystallographic structures of the human A6 abTCR
1996; Lyons et al., 1996; Kersh et al., 1998). According to complexed with the class I MHC molecule HLA-A2, pre-
these suggestions, low affinity or rapidly dissociating senting singly substituted peptides derived from the
interactions would behave as antagonists, higher affinity HTLV-1 Tax peptide (LLFGYPVYV) with partial agonist
or longer-lived interactions as strong agonists, and weak and antagonist activities, are nearly identical to each
and partial agonists would fall between these extremes. other and the abTCR/Tax/HLA-A2 complex (Garboczi
et al., 1996a; Ding et al., 1999). The minor structural
differences observed do not correlate with the T cell§ To whom correspondence should be addressed (e-mail: dcwadmin@
crystal.harvard.edu). response generated; in fact, the two most closely related
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structures are an antagonist and a strong agonist (Ding
et al., 1999). Comparison of two different peptides, one
an agonist (SIYR) and the other a weak agonist self-
peptide (dEV8), in the murine 2C-abTCR/peptide/H-2Kb
complex, also showed only local conformational adjust-
ments, like those between the Tax agonist and the weak
agonist Tax-V7R, where CDR loops rearranged to ac-
commodate the differences in the peptide sequence
(Ding et al., 1999; Degano et al., 2000). Both human
and mouse abTCR structural studies involved potent
agonists: Tax (an HTLV-1 peptide) stimulates 50%-maxi-
mum lysis of HLA-A2 target cells by the 2G4 T cell in
the range of 1 to 10 pM peptide concentration (Ding et
al., 1998, 1999), and SIYR (derived from a peptide library)
stimulates 50%-maximum lysis of H-2Kb targets or
50%-maximum IL-2 production in the range of 10 to 100
pM (Udaka, 1996; Degano, 2000). The weak agonists in
those studies are z1000- to 100,000-fold less potent,
and the antagonists in the human study showed no
agonist activity at 1,000,000-fold higher concentrations
than the 1⁄2-maximal dose of the Tax agonists. Thus, the
full spectrum of activities were included in the human
study and a subset, in the agonist range, in the murine
study (Ding et al., 1999; Degano et al., 2000).
Of the three human abTCR/altered-peptide/HLA-A2
structures, the one most similar to the structure with
the wild-type Tax peptide agonist complex (Garboczi et
Figure 1. Representative Centrifugation Dataal., 1996a) is an antagonist complex with the peptide
(A) Data for 3.2 mM TCR 1 3.3 mM P6A/HLA-A2 (squares, KD 5 116substitution proline 6 to alanine (P6A). The only signifi-
mM) and 2.9 mM TCR 1 3.2 mM Tax wild-type/HLA-A2 (diamonds,cant difference between the abTCR/peptide/HLA-A2
KD 5 1.1 mM) centrifuged at 15,000 rpm. Lines represent fits to astructures with the wild-type and P6A-substituted Tax 1:1 binding model. Residuals (difference between data and fitted
peptides is a packing defect consisting of an enlarged curve) are beneath the data.
(B) Residuals for TCR binding to P6A/HLA-A2 assuming no interac-cavity partially filled with a bound water molecule (Ding
tion (circles, 3.2 mM TCR 1 3.3 mM P6A/HLA-A2, representing 1.4%et al., 1999). Here, we investigate how this packing de-
complex; triangles, 9.3 mM TCR 1 9.5 mM P6A/HLA-A2, representingfect in the interface between the A6 abTCR and the P6A/
3.6% complex). The large-scale and upward deflection of the pointsHLA-A2 complex affects TCR binding and signaling. We
indicates the inadequacy of the fit (compare to residuals in [A], fit
find that the affinity of the A6 abTCR for P6A/HLA-A2 to a binding model).
is very low (116 mM), possibly resulting from a fast disso-
ciation rate. Using structure-based design, we show that
as we attempt to “repair” the packing defect with N-alkyl substitution of proline 6 with alanine (P6A) changes the
amino acid substitutions at peptide position 6, abTCR peptide into an antagonist (Ding et al., 1999). Remark-
affinity increases, and with rising affinity, antagonism ably, the structure of the A6 abTCR/P6A/HLA-A2 com-
disappears and is replaced by weak and then full ago- plex is virtually identical to the structure of the complex
nism. However, measurements of the binding of the A6 with wild-type Tax peptide (rmsd of 0.47 A˚ for interacting
abTCR to HLA-A2 complexed with those N-alkylated P6 TCR/MHC domains and 0.94 A˚ for peptides) (Ding et al.,
peptides with strong agonist behavior suggest that the 1999). Since P6A/HLA-A2 remains an agonist ligand for
range of T cell outcomes does not correlate directly with a second HLA-A2/Tax specific abTCR, B7, it is unlikely
either the affinity or half-life. The possibility that ligands that the P6A substitution affects peptide binding or con-
whose potency does not correlate with measurements formation (Hausmann et al., 1999).
on isolated abTCR would show different kinetic and In our previous study, the affinity of the abTCR A6 for
thermodynamic effects on membrane-bound oligomeric HLA-A2/Tax at 258C was determined as z1 mM with
TCR complexes that might explain their potency in cellu- surface plasmon resonance (Biacore) experiments (Ding
lar assays is discussed. et al., 1999). However, we were unable to detect TCR
binding to HLA-A2 complexed with the P6A peptide,
indicating a weak affinity. Sedimentation equilibrium an-Results
alytical ultracentrifugation, well suited for characterizing
weak equilibria, was thus used to characterize this inter-The Low Affinity of the A6 abTCR for the Antagonist
Ligand P6A/HLA-A2 Was Measured by Sedimentation action. Figure 1A shows centrifugation of a mixture of
the A6 abTCR and P6A/HLA-A2 along with a fit to a 1:1Equilibrium Analytical Ultracentrifugation
In the X-ray structure of the complex between the A6 binding model; the residuals below the plot indicate a
good fit to the model with a KD of 116 mM (Table 1).abTCR, Tax peptide, and HLA-A2, the T cell receptor
does not contact the proline at position 6 of the peptide Analyzing the data with the TCR/peptide/MHC affinity
constrained as a negligible value (i.e., assuming no inter-(closest approach is 4.1 A˚) (Garboczi et al., 1996a). The
Conversion of a T Cell Antagonist into an Agonist
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Table 1. Thermodynamic and Kinetic Parameters at 258C for the A6 abTCR Binding to HLA-A2 with Position 6 Tax Variants
KD Biacore
Tax Peptide KD Ultracentrifuge (mM) Equilibrium (mM) kon (M21 s21) koff (s21) t1/2 (s)a koff/kon (mM)
Wild-typeb 1.1 6 0.1 0.82 6 0.08 1.1 6 0.1 3 105 0.093 6 0.002 7.5 6 0.2 0.9 6 0.1
P6Ac 116 6 34
P6MeGd 26 6 9 27 6 11
P6EtG 2.1 6 0.3 4.2 6 0.6 0.66 6 0.02 3 105 0.23 6 0.01 3.0 6 0.2 3.5 6 0.3
P6PrAe 2.5 6 0.1 0.31 6 0.05 3 105 0.067 6 0.005 10.3 6 0.8 2.2 6 0.4
a t1/2 5 0.693/koff.
b Biacore data for wild-type Tax from Ding et al., 1999.
c No TCR binding with P6A was observed in Biacore experiments (Ding et al., 1999).
d The TCR dissociation rate with P6MeG was too fast to obtain accurate kinetics.
e Analytical ultracentrifugation was not performed with P6PrA.
action) results in significant deviations in the residuals tide/MHC units would be linked to formation of the TCR/
peptide/MHC complex. We can thus conclude that if(Figure 1B), demonstrating the utility of analytical ultra-
centrifugation in resolving this weak affinity. Figure 1A self-association of the A6 abTCR/Tax/HLA-A2 complex
does occur, it is driven by an equilibrium weaker thanalso shows a centrifuge binding experiment using wild-
type Tax peptide; the KD of 1.1 mM obtained is in excel- that governing self-association of the 2B4 abTCR/MCC/
I-Ek complex. No self-association of free A6 abTCR orlent agreement with the values from our previous Bia-
core experiments (z1 mM; Table 1). HLA-A2/Tax was observed in control experiments with
each protein alone (data not shown).Our inability to detect TCR binding with the P6A pep-
tide using Biacore is likely due to a rapid TCR dissocia- Alam et al. (1999) have provided evidence for TCR
dimerization at 378C using Biacore in the form of ation rate. Interactions between TCR and MHC/peptide
molecules with affinities close to or weaker than 100 greater response at 378C than at 258C; however, in their
studies, it is unclear if the injected TCR concentrationmM have been characterized with Biacore (Lyons et al.,
1996; B. B. and D. W., unpublished data), but, in those fully saturated the sensor chip at 258C prior to the higher
temperature injections. Initial analytical ultracentrifuga-cases, the interactions have slow dissociation rates,
allowing a detectable accumulation of protein on the tion experiments at 378C with the A6 abTCR/Tax-pep-
tide/HLA-A2 complex have not provided any evidencesensor chip. The fastest abTCR dissociation rate we
have yet been able to directly measure by Biacore is for dimerization at this temperature (B. B. and D. W.,
unpublished data).1.1 s21 (half-life of 0.63 s) for the A6 abTCR binding to
HLA-A2/Tax with the peptide substitution Y8F (Baker et
al., 2000). We can thus assume that the dissociation Stepwise Repairing of a Packing Defect in the P6A
Structure Restores abTCR Binding Affinityrate of the A6 abTCR from P6A/HLA-A2 is at least as
fast as 1.1 s21 (corresponding to a half-life as short or The interface between the abTCR A6, Tax peptide, and
HLA-A2 is populated by cavities and channels (Garboczishorter than 0.63 s), compared to a rate of 0.093 s21
(half-life of 7.5 s) for dissociation from wild-type Tax/ et al., 1996a; Ding et al., 1999). Upon substitution of
proline 6 of the peptide with alanine, the cavity volumeHLA-A2 (Table 1).
in the interface is increased by 38 A˚3. A water molecule
is found in the enlarged cavity, hydrogen bonding to theNo Self-Association of abTCR/Peptide/MHC
Complexes Was Observed by Ultracentrifugation alanine 6 amide nitrogen and occupying z12 A˚3 (Ding
et al., 1999) (Figures 2A and 2B). Accounting for theWe did not detect any TCR/peptide/MHC self-associa-
tion into oligomeric complexes in the ultracentrifuge ex- water, the actual increase in cavity volume with the P6A
peptide is thus 26 A˚3. We attribute the loss in abTCRperiments, where self-association would be evident as
a systematic deviation from the 1:1 binding model. This affinity for the P6A ligand to this expanded cavity and
bound water, as both internal cavities and bound wateris in contrast to a report of self-association observed
by light scattering for a complex between the mouse molecules are generally considered to be thermodynam-
ically unfavorable (Eriksson et al., 1992; Dunitz et al.,2B4 abTCR and the mouse class II MHC molecule I-Ek
bound to a peptide from moth cytochrome c (MCC) 1994).
As the increase in cavity volume with the P6A peptide(Reich et al., 1997). While our centrifuge experiments
were performed at approximately the same temperature results from removal of two methylenes of the proline
side chain that had been cyclized to the position 6 nitro-as the light scattering measurements (258C versus 218C),
light scattering was performed at an z10-fold higher gen, we reasoned that abTCR affinity should rise if the
increase in cavity volume and fixing of the water mole-concentration than the highest concentration used here
for centrifugation (higher concentrations could not be cule could be limited or prevented. We were also in-
structed by the mechanism of proline recognition by SH3used in the ultracentrifuge due to the limits of the optical
system). However, the affinity of the A6 abTCR for HLA- and WW domains, in which proline or an N-substituted
amino acid is required for binding (Nguyen et al., 1998).A2/Tax is 40-fold higher than the strongest reported
affinity of the 2B4 abTCR for I-Ek/MCC (Lyons et al., We thus designed Tax variants in which position 6 was
replaced with N-alkylated amino acids, varying the alkyl1996; Reich et al., 1997). In solution, without any TCR
or MHC oligomers present, self-association of TCR/pep- chain from one to three carbons (Figure 2E). Binding
Immunity
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Figure 2. Cavity Space and Peptide Position 6 Substitutions
(A) Cavity space (mesh) around peptide position 6 in the structure with wild-type Tax. The orientation is such that the TCR is above the plane
of the page and the MHC below. Proline 6 side chain is red; the amide nitrogen is blue.
(B) Increase in cavity volume (mesh) and bound water (cyan sphere) in the P6A structure relative to the structure with wild-type Tax. Orientation
and coloring is the same as in (A).
(C and D) Increase in cavity volume (mesh) with P6MeG (C) and P6EtG (D) relative to the structure with wild-type Tax. Orientation and coloring
is as in (A).
(E) Peptide position 6 substitutions used in this study. Amide nitrogen is blue.
of each modified-peptide/HLA-A2 complex to the A6 N-methyl carbon added). The stronger abTCR affinity
for the P6MeG ligand relative to P6A is, thus, probablyabTCR was measured by Biacore and/or analytical ultra-
centrifugation. Figure 3 shows representative kinetic attributable to dissociation of the bound water, forced
by methylation of the amide nitrogen.and equilibrium Biacore data; the results for each pep-
tide are summarized in Table 1.
Tax-P6!N-Ethyl Glycine
Tax with N-ethyl glycine at position 6 (P6EtG) has aTax-P6!N-Methyl Glycine
Tax with N-methyl glycine (sarcosine) at position 6 TCR affinity of 2.1 mM (centrifuge data), or an z60-fold
increase over TCR affinity with the P6A peptide (116(P6MeG) has an abTCR dissociation constant of 26 mM
(centrifuge data) or a greater than 4-fold increase in mM) (Table 1). This peptide is similar to the P6MeG pep-
tide, with an ethyl rather than a methyl group added toaffinity relative to P6A (Table 1). Unlike P6A, we could
observe TCR binding with the P6MeG peptide using the amide nitrogen of position 6. Assuming the ethyl
group is oriented similarly to the g and d carbons of theBiacore. The KD from a Biacore equilibrium experiment,
27 mM, is identical within error to that obtained by analyt- original proline side chain, this peptide completely fills
the enlarged cavity created by the P6A substitution (Fig-ical ultracentrifugation (Table 1). However, the abTCR
dissociation rate was still too fast to permit reliable ki- ure 2D). However, there is still a 13 A˚3 increase in cavity
volume relative to the wild-type peptide, resulting fromnetic measurements (Figure 3C).
Although the P6MeG peptide is missing the b carbon deletion of the b carbon, which is likely the main reason
why TCR affinity with this peptide is slightly weaker thanfrom position 6, it has a methyl group on the amide
nitrogen that points directly toward the enlarged cavity with wild-type.
Unlike P6A and P6MeG, high-quality kinetic data(Figure 2C). It is likely that the bound water in the P6A
structure is excluded from the cavity in the P6MeG pep- could be measured by Biacore with the P6EtG peptide
(Figure 3A; values in Table 1). The abTCR associationtide complex, as modeling indicates a steric clash be-
tween the N-methyl group and the bound water in the rate (kon) is 6.6 3 104 M21 s21, z1/2 of the rate observed
with wild-type Tax. The dissociation rate (koff) is 0.23 s21,P6A complex.
Calculations with a modeled structure indicate that corresponding to a TCR/peptide/MHC half-life of z3 s.
This is 2.5-fold shorter than the half-life of the complexthe increase in cavity volume with the P6MeG peptide
relative to wild-type Tax is 39 A˚3, nearly identical to the with wild-type Tax (7.5 s; see Table 1). As discussed
below, the half-life and TCR affinity of the P6EtG com-increase in cavity volume with the P6A peptide (38 A˚3;
because the b carbon of alanine was deleted and an plex is almost but not quite equal to that of the Tax
Conversion of a T Cell Antagonist into an Agonist
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pyl group could extend into the cavity near proline 6
present in the wild-type Tax complex if the b carbon of
alanine were retained to prevent the propyl group from
bending toward the a carbon to form a structure analo-
gous to proline.
Although we aimed to reduce the cavity volume with
the P6PrA peptide and, thus, increase abTCR affinity,
binding measurements indicated that the abTCR affinity
(KD 5 2.2 mM; Table 1) is slightly weaker than that ob-
served for wild-type Tax (KD 5 z1 mM). Despite a weaker
affinity, however, kinetic measurements show a longer
half-life relative to wild-type Tax (P6PrA t1/2 5 10.3 s,
wild-type 5 7.5 s). The longer half-life suggests that the
P6PrA peptide achieves our goal of reducing the cavity
space around position 6 but at the expense of an z70%
decrease in the association rate constant (from z1.1 3
105 M21 s21 for Tax to z0.3 3 105 M21 s21 for P6PrA),
which results in a weaker TCR affinity. The decrease in
kon may be due to the need to fix the two torsion angles
of the propyl group.
Thermodynamic Analysis of Cavity Volume
and Bound Water
Binding of the A6 abTCR to HLA-A2/Tax results in a
conformational change in the peptide (Garboczi et al.,
1996a). In the structure of HLA-A2/Tax without the
abTCR bound, the side chain of proline 6 is positioned
away from the peptide binding groove (Madden et al.,
1993); with the abTCR bound, the proline is angled down
into the groove. A water molecule found in the peptide
binding groove beneath the proline must be displaced
by this peptide conformational change (Khan et al.,
2000). Presumably, displacing the bound water into the
bulk solvent is thermodynamically favorable, contribut-
ing to the abTCR binding affinity. When the A6 abTCR
Figure 3. Representative Biacore Data binds the P6A ligand, the water is not forced out. Rather,
(A) Kinetic data for P6EtG/HLA-A2 binding to A6. Data are in black; it is retained in the peptide binding groove to hydrogen
red represents a fit to a 1:1 binding model. Concentrations of in- bond to the free amide nitrogen at P6, occupying z12 A˚3
jected protein are indicated. Residuals for the fitted portions of the of the 38 A˚3 cavity created by the P6A substitution.
curve are beneath the data.
The DDG8 between abTCR binding to the P6A and(B) Equilibrium binding data for P6EtG/HLA-A2 binding to A6. Line
P6MeG ligands is z900 cal/mol (DDG8 5 2RTln KD1/KD2).represents a fit to a 1:1 binding model (KD 5 4.2 mM).
This includes contributions from an unfavorable net in-(C) Representative dissociation phases from kinetic experiments.
From left (fastest) to right (slowest): P6MeG, P6EtG, wild-type Tax, crease in cavity volume for P6MeG of 12 A˚3 (the volume
and P6PrA. The affinity of the MHC/peptide for the A6 TCR, the half- of the water molecule displaced by the N-methylation)
life of the TCR/peptide/MHC complex, and the relative cytotoxic that at a free energy cost of cavity formation ranging
potency of each ligand are indicated.
from 24 to 33 cal/mol/A˚3 (Eriksson et al., 1992) would
be only z360 cal/mole. However, there are considerable
uncertainties in estimating cavity effects (Eriksson et al.,complex because the position 6 b carbon atom is
1992). A favorable free energy gain is expected frommissing.
release of the water, but its high B factor (50 A˚2) suggests
that the entropic gain from its release is small (Dunitz
et al., 1994). This analysis suggests that there may beTax-P6!N-Propyl Alanine
As shown in Figures 2A and 2B, the packing defect a favorable enthalpy change associated with release of
the water.observed with P6A results from the enlargement of the
cavity adjacent to the position 6 side chain. Having dem- The DDG8 between abTCR binding to the P6MeG and
P6EtG ligands, which differ by one methylene group, isonstrated that “repairing” the packing defect with P6EtG
can restore abTCR binding affinity, we attempted to z1.5 kcal/mol. This agrees well with the value for the
average stability loss incurred by deletion of methylincrease abTCR affinity above that observed with wild-
type Tax by filling cavity space found in the wild-type groups within the core of a protein (1.3 kcal/mol) (Jack-
son et al., 1993). The increase in cavity volume relativeTax complex near proline 6. By substituting N-propyl
alanine at position 6 (P6PrA), we retained the b carbon to the wild-type Tax peptide modeled with P6MeG is
39 A˚3; with P6EtG it is 13 A˚3, yielding a difference ofas in alanine but added a third carbon to the N-alkyl
substitution (Figure 2E). Modeling indicated that the pro- 26 A˚3. If the only effect were due to the change in cavity
Immunity
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volume (this is unlikely as there may be small structural
reorganizations with the N-substituted peptides), the
free energy cost per cubic angstrom would be z58 cal/
mol, larger than the estimate of 24–33 cal/mol (Eriksson
et al., 1992).
The DDG8 from the KD measurements of the abTCR
binding to the wild-type and P6EtG ligands is z400 cal/
mol. This is approximately what is expected from the
increase of 13 A˚3 in cavity volume (z390 cal/mol). How-
ever, there could also be other effects, such as an en-
tropic penalty from fixing the torsion angle in the ethyl
group of P6EtG.
Finally, since TCR affinity can be restored to near wild-
type level with a glycine-based N-alkylated amino acid
at position 6, the loss of TCR binding affinity with the
P6A peptide cannot be attributed to an entropic penalty
resulting from increased flexibility of the peptide upon
substituting proline with alanine; as to a first approxima-
tion, the backbone conformational entropy of an N-alkyl-
ated glycine should resemble that of alanine.
As Affinity Increases, TCR Antagonism Is Replaced
by Weak and Then Full Agonism
The position 6 Tax variants were examined in a T cell
assay measuring lysis of antigen-presenting cells (Fig-
ure 4A). As previously observed, P6A has little or no
stimulatory activity, even when presented at concentra-
tions several orders of magnitude above that required
to elicit a response with wild-type Tax (Figure 4A, also
Figure 2A in Ding et al., 1999). P6A is an antagonist if
presented in 1000-fold excess over Tax (Figure 4B; also
Figure 1F in Ding et al., 1999). The assays indicate that
Figure 4. T Cell AssaysP6MeG is a weak agonist (not an antagonist; Figure 4B),
(A) Cytotoxicity of HLA-A2 targets pulsed with position 6 Tax peptidewhile P6EtG and P6PrA are strong agonists (Figure 4A).
variants mediated by the A6 TCR-bearing clone 2G4. Effector: targetThe assay also indicates that P6EtG has a stimulatory
ratio 5 2.5:1. Identical rank ordering of activity was observed withactivity even greater than wild-type Tax, an effect that
IFN-g and MIP-1b release as described in the text.
was reproducible over several repeated experiments (B) P6A but not P6MeG antagonizes secretion of IFN-g induced by
(Experimental Procedures). The same rank order, includ- the Tax peptide. The A6 TCR-bearing clone RS56 was cultured with
ing the increased activity of P6EtG, was observed in antigen-presenting cells pulsed with 1000 nM candidate antagonist
peptides (influenza M1 58–66 served as a negative control) for 2 hrcytokine release assays measuring IFN-g and MIP-1b
at 378C, and then, 1 nM Tax peptide was added. IFN-g secretion(data not shown).
was quantitated after 48 hr. Quantitative differences relative to theExamination of TCR signaling by analysis of phos-
negative control were analyzed by the Student’s t test.phorylation of the TCR-associated z chains and ZAP-
(C) TCR signaling measured by phosphorylation of the TCR-associ-
70 (Figure 4C) demonstrates that Tax, P6EtG, and P6PrA ated j chains and ZAP-70. HLA-A2 antigen-presenting cells were
stimulation induced a pattern of strong phosphorylation pulsed with 10 mM of each peptide and used to stimulate the A6
of the TCR-associated z chains and ZAP-70, a pattern TCR-bearing clone RS56. Results are presented as densitometry
readings from an autoradiogram and are representative of two re-typical of TCR signaling induced by agonists. T cell
peated experiments.stimulation with P6MeG and P6A induced no detectable
ZAP-70 phosphorylation and little z chain phosphoryla-
tion, a pattern typical of signaling by very weak agonists
structures of the complexes of these two ligands withand antagonists (Sloan-Lancaster and Allen, 1996). We
the A6 abTCR are essentially identical (Ding et al., 1999),observed nearly identical patterns of z phosphorylation
and there is no contact between either the position 6with the three agonist peptides, wild-type Tax, P6EtG,
proline or the alanine with the abTCR (Garboczi et al.,and P6PrA, despite the 3-fold range of TCR/peptide/
1996a; Ding et al., 1999). Thus, alterations in the abTCRMHC complex half-lives (10.3–3.0 s). This result con-
structure were apparently not responsible for the verytrasts with the z phosphorylation patterns seen with
considerable difference in the TCR-initiated T cell signal.the mouse class II restricted abTCR 3.L2, which were
The only property of the interfaces that differed was anreported to vary considerably with MHC/peptide ligands
increase in cavity volume and a bound water moleculewith TCR affinities and half-lives of similar magnitude
(not contacted by the abTCR) in the P6A complex (Fig-and range to those observed here (Kersh et al., 1998).
ures 2A and 2B). (The difference in solvation free energy
between the proline- and alanine-containing peptide inDiscussion
the TCR-free HLA-Tax complex, calculated by molecular
dynamics simulation, makes a significant contributionHere, we studied variants of the HLA-A2/Tax agonist
and HLA-A2/P6A antagonist ligands because the X-ray to the better binding of the wild-type to the TCR [O.
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Michielin and M. Karplus, personal communication].) when measurements are performed at 378C. However,
the growing number of ligands whose potency does notUsing N-alkyl substitutions at position 6, we have in
stepwise fashion filled in the part of the cavity occupied correlate well with affinity and half-life suggests that
other interpretations may have to be sought.by the proline side chain, resulting in displacement of
the bound water molecule. Consistent with our hypothe- A limitation of X-ray structures and kinetic and ther-
modynamic measurements of MHC/peptide ligandssis that the enlarged cavity and bound water converted
an agonist to an antagonist, the series of MHC/peptide with only the ab chains of the TCR is that the CD3 and
z subunits are lacking. Furthermore, the stoichiometryligands generated by N-alkyl substitution did, in step-
wise fashion, restore agonist activity. of the membrane-bound unliganded ground-state struc-
ture of the complete oligomeric TCR complex found onHowever, when the affinity of the series of MHC/pep-
tide ligands for the abTCR and the half-lives of the MHC/ T cells is uncertain. Some evidence suggests that this
complex contains two abTCRs as well as CD3 and zpeptide/abTCR complexes were measured, two anoma-
lies were observed. Although the half-life of the P6PrA subunits (Exley et al., 1995; San Jose´ et al., 1998; Ferna´n-
dez-Miguel et al., 1999; Cochran et al., 2000). Thecomplex was longer than Tax (10.3 versus 7.5 s; Table
1; Figure 3C), they had the same potency (Figure 4A), abTCR/peptide/MHC interfaces observed crystallo-
graphically are probably good representations of thoseand, although the half-life of the P6EtG was shorter than
Tax (3 versus 7.5 s; Table 1; Figure 3C), it was a 10-fold present with membrane-bound TCR because the study
of many complexes has revealed good evidence of indi-more potent agonist (Figure 4A). These half-life differ-
ences are readily observed (Figure 3C) and accurately vidualized induced fits between different abTCRs and
their ligands and between variant ligands and the samemeasurable (Table 1). In earlier studies of HLA-A2/pep-
tide and H2-Kb/peptide ligands, half-life differences of abTCR (Garboczi et al., 1996a; Ding et al., 1998, 1999;
Garcia et al., 1998; Reinherz et al., 1999; Degano et al.,5- and 3-fold in the 1–10 s range are associated with
10,000- to 100,000-fold differences in agonist potency 2000; Hennecke et al., 2000). But, whether CD3, z, or
the cell surface oligomeric state of the TCR place re-(as measured by the difference in peptide concentration
required for half-maximal lysis or IL-2 production) straints on the disposition or conformation of the Ca
and Cb domains and/or the relationship of the V domains(Udaka et al., 1996; Ding et al., 1999; Degano et al.,
2000). Here, great care was taken to measure the kinetic to the C domains is unknown.
Although the P6EtG and P6PrA complexes all haveconstants accurately by fitting the data over the entire
time range and correcting for bulk refractive index half-lives above a reasonable threshold for agonist activ-
ity, what is the physical basis for the relative differenceschanges (Myszka, 1999). Furthermore, independent
equilibrium and kinetic affinity measurements made with in TCR signaling potency if there is no correlation with
half-life or affinity? Apparently, there are two classes ofBiacore were consistent with each other and with affinity
measurements made by sedimentation equilibrium ana- MHC/peptide ligands based on the kinetic and thermo-
dynamic data on ligand/abTCR complexes: those li-lytical ultracentrifugation (Table 1).
Although many MHC/peptide ligands both from this gands whose potency correlates with complex affinity
and half-life and those ligands that do not. Models for thestudy and others (Alam et al., 1996; Lyons et al., 1996;
Kersh et al., 1998; Ding et al., 1999; Baker et al., 2000; signaling mechanisms of those ligands whose potency
correlates with half-life (or affinity) envision the peptide/Degano et al., 2000;) stimulate different T cell signals in
proportion to the half-life of the complex they form with MHC ligand stabilizing the TCR in a state that initiates
signals by (for example) assembly to higher order struc-an abTCR, a number of MHC/peptide combinations,
including two studied here, do not fit this model. Exam- tures or conformational changes (e.g., Janeway et al.,
1989; McKeithan et al., 1995). All of the ligand/abTCRples include an antagonist ligand that formed abTCR
complexes with a half-life almost twice as long as that X-ray structures have been interpreted to correlate, at
least qualitatively, with the abTCR affinities, but struc-observed with a weak agonist ligand (Alam et al., 1996);
three mutant-HLA-A2/Tax ligands that form abTCR tural differences that would explain the anomalous
cases of biological potency are not apparent. This raisescomplexes with half-lives from 7 to 25 s, in the range
of agonists, but which are weak agonists or null ligands the possibility that ligands whose potency does not cor-
relate with the available measurements on isolated(B. B., and D. W., unpublished data); an antagonist with
30-fold higher affinity than a weak agonist (Sykulev et abTCR would show different kinetic and thermodynamic
effects on intact, oligomeric TCR. The biological potencyal., 1998); an agonist with very weak TCR binding affinity
(al-Ramadi et al., 1995); and the P6EtG/HLA-A2 and of these ligands may be mediated by their effects on
the structurally uncharacterized ground-state TCR. ForP6PrA/HLA-A2 ligands studied here, where the half-lives
of the abTCR complexes (Figure 3C; Table 1) do not example, if the ground-state cell surface TCR, before
any ligand binds, contains two abTCRs, the dimericcorrelate with the agonist potency (Figure 4A). Compli-
cated binding kinetics have been observed for TCR assembly may impose restraints on the individual
abTCRs that decrease their affinities for some ligandsbinding to agonist ligands at 378C (Alam et al., 1999)
(the observations interpreted by Alam et al. [1999] as (like hemoglobin [Hb] does for oxygen) and increase
their affinity for others (like Hb for Bohr protons) (MonodTCR dimerization would not have been observed here,
as we did not perform experiments at 378C, and the et al., 1965; Perutz, 1989).
Restraints imposed by oligomeric assemblies, suchpeptide/MHC was not attached to the Biacore chip). It
remains to be determined if the anomalies observed as those distinguishing tetrameric hemoglobin from a
monomeric hemoglobin subunit, are the structural basishere at 258C remain at 378C. It is a formal possibility
that the P6EtG, P6PrA, and wild-type ligands will have for cooperativity and allosteric regulation in proteins
(Monod et al., 1965; Perutz, 1989). Such restraints candifferent temperature dependencies and yield a better
correlation of cytotoxic activity with half-life or affinity have profound effects on the affinities and kinetics of
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calculated as described (Durchshlag, 1986). Fitted molecularligand interactions; for example, monomeric hemoglo-
weights were within 2% of the values calculated from sequence.bin subunits have a high affinity for oxygen, while the
For measuring binding, three samples of proteins mixed at differ-restraints of the tetrameric assembly (in the thermody-
ent concentrations were used. Concentrations were determined by
namically favored deoxy quarternary conformation) de- preparing stocks of twice the desired value and mixing equal vol-
crease the affinity of the same hemoglobin polypeptide umes; final concentrations were nearly equimolar and ranged from
3 to 9 mM. Samples were centrifuged as above, except that datachain by 25- to 500-fold (Dickerson and Geis, 1983). To
were recorded at 255 nm. Data were analyzed with a 1:1 bindingdate, all structural and detailed kinetic and thermody-
model:namic measurements have been made on monomeric
abTCR. Oligomeric restraints on TCR might affect ligand
cr 5 dist A 1 dist B 1 c0Ac0B K exp 1MAB (1 2 mABq) v
2
RT
(x2 2 x20)2 1 b (2)kinetics or affinities. Some ligands may be able to bind
the restrained state and induce it to change conforma-
The terms dist A and dist B in Equation 2 represent the distribution
tion to a less restrained conformation—a conformation, of free TCR and peptide/MHC according to Equation 1 (excluding the
perhaps, similar to that seen in monomeric abTCR. Such baseline), except that data is expressed in terms of concentration, c.
a mechanism has been described for molecular cooper- Absorbances were converted to concentrations during fitting using
extinction coefficients at 255 nm. The third term in Equation 2 isativity in sequential models of allosteric control (Kosh-
the distrubution of the TCR/peptide/MHC complex; the referenceland et al., 1966). This proposal is similar to earlier sug-
concentration is the product of the free reference concentrationsgestions that conformational changes play a role in TCR
for the TCR and peptide/MHC and an equilibrium association con-
signaling (e.g., Janeway, 1995), the difference being that stant, K (KD 5 1/K). The partial specific volume of the complex
rather than a conformational change occurring in a (mAB) was calculated as a weight average. Fitting was performed with
receptor containing only one abTCR, a change is pro- reference concentrations and baselines as local parameters for each
of the six data sets and with K as a global parameter. Due to overpar-posed to occur as an unliganded oligomeric ground-
ameterization, it was necessary to exclude a reference concentra-state TCR complex transforms to a fully liganded com-
tion during fitting using the conservation of mass approach (Becerraplex. The existence of well-documented effects of
et al., 1991). Cell boundaries were determined from scans at 360
ligands that do not fit models based on a monomeric nm where absorption was minimal. The fraction of TCR/peptide/
abTCR ground-state suggests that their explanation will MHC complexes present over the concentration ranges used ranged
require studies of the structure, thermodynamics, and from z1% to 4% for P6A/HLA-A2 to 28% to 64% for wild-type Tax/
HLA-A2.kinetics of a putative oligomeric cooperative TCR entity.
Surface Plasmon Resonance (Biacore)
Experimental Procedures
Biacore measurements were performed using Biacore 1000 and
2000 instruments (Biacore, Uppsala, Sweden) as described (Ding
Proteins and Peptides
et al., 1999). In brief, the TCR was coupled to a sensor chip using
HLA-A2 and A6 abTCR were refolded as soluble ectodomains from
the free thiol engineered at the C terminus of the b chain. Equilibrium
E. coli inclusion bodies as previously described (Garboczi et al.,
experiments were performed by injecting 70 ml of MHC/peptide at
1992, 1996b). Peptides were synthesized by Commonwealth Bio-
a flow of 10 mL/min. The response was determined by averaging
technologies (Richmond, VA) and HPLC purified to . 95% purity.
the signal over the final 15 s of the injection and subtracting the
High peptide/MHC refolding yields indicated that peptide binding
response from an identical injection over a mock cysteine-coupled
to the MHC was not impaired with any of the studied peptides.
flowcell. Data were fit versus concentration to a 1:1 binding model.
The abTCR used in all experiments contains the a and b chains
For kinetic experiments, 60 ml of MHC/peptide was injected at a
up to and including the cysteines encoding the interchain disulfide
flow of 100 mL/min. Identical injections over the mock flowcell were
bond, followed by a heterodimeric coiled coil (O’Shea et al., 1993) to
subtracted from the data. The entire association and dissociation
stabilize the ab dimer during refolding and analysis. A free cysteine is
phases were fit to a 1:1 binding model, excluding z2 s at the begin-
present at the C terminus of the b chain for coupling to a Biacore
ning of each phase. As with our previous studies, we included a
chip. Protein concentrations for all measurements were determined
term for a small baseline drift during fitting (Ding et al., 1999; Baker
in triplicate and the average result used; extinction coefficients at
et al., 2000). Inclusion of this term improved the residuals but had
280 nm were 95,839 M21 cm21 for Tax/HLA-A2 and 84,503 M21 cm21
only a minor effect on the fitted parameters. Conditions for all experi-
for the A6 TCR (Ding et al., 1999).
ments were 10 mM HEPES, 150 mM NaCl, 3 mM EDTA, 0.005%
polysorbate-20 (pH 7.4), and 258C. Injections were repeated twice.
Fitting was performed using Biavaluation 3.0 (Biacore). For the equi-Analytical Ultracentrifugation
librium experiments, errors in Table 1 are the standard fitting error.Analytical ultracentrifugation was performed using a Beckman XL-A
Errors in kinetic constants are standard deviations from multipleinstrument (Beckman, Palo Alto, CA). For analysis of individual pro-
determinations. Errors in half-lives and kon/koff values were deter-teins, three concentrations (MHC: 1, 3, and 7 mM; TCR: 1, 3, and 6
mined by standard statistical error propagation.mM) of each protein were centrifuged at 12,500 and 15,000 rpm.
Conditions were 10 mM phosphate, 150 mM NaCl (pH 7.4), and 258C.
Concentration versus position was recorded using absorbance at Cavity Calculations
280 nm. Equilibrium was assumed when subtraction of scans taken Cavity calculations were performed using the program SURFNET
4 hr apart showed no deviations. The six data sets for each sample (Laskowski, 1995). All atoms of the TCR Va/Vb and MHC a1/a2
were globally fit to the following equation using the program NONLIN domains and the peptide were included in the calculations; volume
(Johnson and Frasier, 1985): changes were calculated as differences in total cavity volume. Struc-
tures were modeled by adding or removing atoms from the structure
of the complex with the wild-type Tax peptide (Protein Data BankAr 5 A0 exp 1M(1 2 mq) v
2
RT
(x2 2 x20)2 1 b (1) entry 1AO7). Similar results were obtained using the structure with
the P6A peptide (Protein Data Bank entry 1QRN) as the starting
structure. Optimum, minimum, and maximum probe radii were foundwhere Ar is the absorbance at radial position r; A0 is the absorbance
at the meniscus; M, the protein molecular weight; v, the rotor angular by varying the parameters until further changes produced no signifi-
cant changes in difference cavity volumes. Grid spacing was 0.6 A˚.velocity; RT, the product of the gas constant and temperature; x,
the radial position; and b, a baseline offset. The variables A0 and b The increase in cavity volume with P6A is larger than previously
reported (Ding et al., 1999); our previous report underestimated thewere local parameters for each data set, whereas M was a global
parameter. Partial specific volumes (m) and solvent density (r) were increase in cavity volume as the calculations were restricted to only
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the atoms of peptide position 6 and the MHC a1/a2 domains. As recognition in a superagonist TCR/MHC complex. Immunity 12,
251–261.SURFNET uses atom pairs to calculate cavities, limiting the calcula-
tion in this manner results in an incomplete exploration of cavity Dickerson, R.E., and Geis, I. (1983). Hemoglobin: Structure, Func-
space. tion, Evolution and Pathology. (Menlo Park, CA: Benjamin/Cum-
Figures 2B through 2D represent actual changes in cavity volume mings, Inc.).
and were generated with the MAPDIFF program distributed with
Ding, Y.H., Smith, K.J., Garboczi, D.N., Utz, U., Biddison, W.E., andSURFNET using results from the calculations of total cavity volume.
Wiley, D.C. (1998). Two human T cell receptors bind in a similarTo make Figure 2A, the calculation was limited to the atoms of
diagonal mode to the HLA-A2/Tax peptide complex using differentproline 6 (excluding the carbonyl) and all atoms of the TCR Va/Vb
TCR amino acids. Immunity 8, 403–411.and MHC a1/a2 domains. This simplification allows visualization of
Ding, Y.H., Baker, B.M., Garboczi, D.N., Biddison, W.E., and Wiley,only the regions of cavity space in the A6 TCR/Tax/HLA-A2 interface
D.C. (1999). Four A6-TCR/peptide/HLA-A2 structures that generatethat are adjacent to proline 6.
very different T cell signals are nearly identical. Immunity 11, 45–56.
T Cell Assays Dunitz, J.D. (1994). The entropic cost of bound water in crystals and
Cytotoxicity was quantitated with a fluorometric assay using HLA- biomolecules. Science 264, 670–670.
A2-transfected cells as previously described (Ding et al., 1998). Ef- Durchshlag, H. (1986). Thermodynamic Data for Biochemistry and
fector cells were the A6-expressing CD81 T cell clone 2G4 (Utz et Biotechnology. (New York: Springer-Verlag).
al., 1996). IFN-g, MIP-1b, and antagonism assays were performed
Eriksson, A.E., Baase, W.A., Zhang, X.J., Heinz, D.W., Blaber, M.,using the A6-expressing CD81 T cell clone RS56 as previously de-
Baldwin, E.P., and Matthews, B.W. (1992). Response to a proteinscribed (Utz et al., 1996; Ding et al., 1999). TCR-associated signaling
structure to cavity-creating mutations and its relation to the hy-was assayed with anti-phospho-tyrosine antibodies and quantitated
drophobic effect. Science 255, 178–183.with densitometry as described (Ding et al., 1999).
Exley, M., Wileman, T., Mueller, B., and Terhorst, C. (1995). EvidenceP6EtG had higher activity than wild-type Tax in the cytotoxicity,
for multivalent structure of T-cell antigen receptor complex. Mol.IFN-g, and MIP-1b assays. The assays were repeated several times
Immunol. 32, 829–839.with different peptide stocks, and each time the same result was
observed. This cannot be attributed to small errors in peptide con- Ferna´ndez-Miguel, G., Alarco´n, B., Iglesias, A., Bluethmann, H., Al-
centration, as the assays are performed on a logarithmic scale. All varez-Mon, M., Sanz, E., and de la Hera, A. (1999). Multivalent struc-
peptides were prepared in the same fashion, purified by HPLC, ture of an abT cell receptor. Proc. Natl. Acad. Sci. USA 96, 1547–
and appeared to have comparable solubilities. An attempt to limit 1552.
potential peptide proteolysis by performing the experiments in se- Garboczi, D.N., Hung, D.T., and Wiley, D.C. (1992). HLA-A2-peptide
rum-free conditions produced the same hierarchy of peptide activ- complexes: refolding and crystallization of molecules expressed in
ity, indicating differential proteolysis from proteases that may be Escherichia coli and complexed with single antigenic peptides.
present in serum is not a contributing factor. Proc. Natl. Acad. Sci. USA 89, 3429–3433.
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